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AbstrACt 
Objectives Healthcare process carries important 
prognostic information for patients, but the healthcare 
processes of laboratory tests have not yet been 
investigated for patients in the intensive care unit (ICU). 
The study aimed to investigate the effect of healthcare 
processes of laboratory tests on hospital mortality, with the 
hypothesis that the addition of healthcare processes could 
improve the discrimination for mortality outcome.
Design The study included 12 laboratory tests. There 
were two dimensions for each laboratory test. One was the 
pathophysiology value; and the other was the healthcare 
process variables including the clock hour, the number 
of measurements and the measurement time from ICU 
admission. Generalised additive model was employed to 
investigate the effect of continuous variables on mortality. 
Generalised linear models with and without healthcare 
process variables were compared for their discrimination 
power.
setting ICUs in an US-based hospital.
Participants Adult patients included in the critical care 
big data Medical Information Mart for Intensive Care.
Primary and secondary outcome measures The 
hospital mortality was the primary outcome.
results A total of 52 963 adult patients with complete ICU 
stay information were included for analysis. The mortality rate 
was 12.3%. Lower number of tests such as 1–3 times were 
associated with the lowest mortality for most laboratory tests. 
However, the hematocrit, glucose and potassium required 
6–10 measurements for the first 24 hours to reach the lowest 
mortality rate. In n of the 12 prediction models involving 
laboratory tests, the addition of healthcare process variables 
was associated with significantly increased area under 
receiver operating characteristics.
Conclusions The study showed that healthcare processes 
of laboratory tests were independently associated with 
hospital mortality. The addition of healthcare processes 
to the pathophysiology value could increase the 
discrimination for mortality outcome.
IntrODuCtIOn
Electronic healthcare records (EHRs) have 
been widely used in modern hospitals, 
allowing the generation of a massive data 
via routine clinical practice. These data can 
help to improve healthcare management 
and provide large volume of data for medical 
researches. Laboratory tests are one of the 
most widely used variables in healthcare and 
biomedical researches because they are struc-
turalised in most EHRs. There are generally 
two dimensions of a laboratory test which are 
the pathophysiological value and the health-
care process. The idea is that EHR laboratory 
test data reflect both the pathophysiology of 
a patient as well as the clinician’s decision to 
order the test. Processes within the health-
care system, such as clinic hours and when 
hospital rounds occur, determine when most 
tests are ordered. Tests that are ordered at 
unusual times or frequency suggest that the 
clinician was concerned about the patient’s 
state of health. Variables associated with 
healthcare processes, such as the time of day 
strengths and limitations of this study
 ► The study employed a large clinical database 
showing that healthcare processes of laboratory 
tests were independently associated with hospital 
mortality.
 ► The addition of the healthcare processes to the 
pathophysiology value could increase the discrimi-
nation for mortality outcome.
 ► Healthcare process modelling can be incorporat-
ed into the assessment of the severity of illness 
on the first 24 hours after intensive care unit (ICU) 
admission.
 ► Impact of healthcare processes of laboratory tests 
can be different for patients in ICU and those in the 
outpatient or general ward.
 ► The study is limited by a single-centre design in that 
different institutions may have different healthcare 
process that can have distinct impact on mortality 
outcome.
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of the test, can therefore provide additional insight into 
the patient’s health, which can improve the accuracy of 
predictive models. Some widely investigated healthcare 
processes, including the timing of hospital admission, 
surgical procedures on weekends and handover during 
anaesthesia, have been shown to be associated with clin-
ical outcomes.1–4 More recently, healthcare processes of 
the laboratory tests, such as the hour of day for ordering 
a test, day of the week and period since the last test, have 
been investigated in the hospitalised patients, and the 
results showed that these healthcare process variables 
were associated with the survival outcome, independent 
of their pathophysiology values.5 While pathophysiology 
values directly measures patients’ health, the healthcare 
process variables such as the frequency of a test can reflect 
providers’ knowledge of their patients’ state of health.6 
Intensive care unit (ICU) is a hospital ward where 
critically ill patients are closely monitored, generating 
a high granularity of data. Several healthcare processes 
have been analysed in the ICU, such as ICU admission 
outside daytime hours,7 weekend admission8 9 and the 
time of discharge.10 However, the healthcare processes 
of laboratory tests have not been investigated in ICU. 
The study aimed to investigate the effect of healthcare 
processes of laboratory tests on hospital mortality. We 
hypothesised that (1) healthcare processes (eg, clock 
time of laboratory tests, number of measurements and 
the time from ICU admission to tests) of laboratory tests 
are independently associated with the hospital mortality 
and (2) the models including pathophysiology values 
and healthcare processes would have greater discrim-
ination power than the models with pathophysiology 
values alone.
MethODs
Data source
A large US-based critical care database named Medical 
Information Mart for Intensive Care (MIMIC-III) was 
employed for this study.11 MIMIC-III integrates deidenti-
fied, comprehensive clinical data of the patients admitted 
to the ICUs of Beth Israel Deaconess Medical Centre in 
Boston, Massachusetts, from 1 June 2001 to 31 October 
2012. There were 53 423 distinct hospital admissions for 
adult patients (aged 16 years or above) admitted to ICUs 
during the study period. The study was an analysis of the 
third-party anonymised publicly available database with 
pre-existing institutional review board approval. ZZ had 
obtained permission to access the database after comple-
tion of the course Data or Specimens Only Research 
(approval no: 28776374).
Laboratory tests
The study included 12 laboratory blood tests which were 
bicarbonate, hematocrit, potassium, blood urea nitrogen 
(BUN), glucose, white cell count (WBC), creatinine, 
pH, sodium, albumin and bilirubin. These variables 
were chosen because they were included in the acute 
physiological score component of the Acute Physiology 
and Chronic Health Evaluation (APACHE) III score, 
indicating that their pathophysiology values were good 
measures of the acute severity of illness.12 The charting 
time of these tests was extracted. In the MIMIC-III data-
base, the ‘chart time’ of a laboratory variable is the time at 
which a measurement is recorded. In almost all the cases, 
this is the time which best matches the time of actual 
measurement. The laboratory variables measured within 
the first 24 hours after ICU admission were obtained for 
the analysis. The time window was defined as the differ-
ence between the chart time of laboratory test and the 
ICU admission time, and it should be less than 24 hours. 
The reason for considering only the first 24 hours was 
because many severity scores like APACHE II or III were 
calculated during this time window, and mortality predic-
tion was made based on variables measured in this time 
window.13 14 The laboratory tests were collected for routine 
patient care, not for the research purpose. The quality 
and reliability of the tests were the same as those used 
for patient care. The measurements were performed by 
the laboratory of Beth Israel Deaconess Medical Center 
in Boston.
There were two dimensions for each laboratory test. 
One was the pathophysiology value, which was well known 
as a measure of health conditions. The other value was 
the healthcare process variables including the hour of 
the day when a test was ordered, the number of repeated 
measurements of a test for the first 24 hours after ICU 
admission, and the measurement time relative to ICU 
admission.
statistical description
Baseline characteristics of the entire cohort were 
expressed as the median and IQR for continuous vari-
ables, and as the number and percentage for categor-
ical variables. The length of stay (LOS) in the ICU and 
hospital were expressed as a median and IQR. Mortality 
outcome was expressed as the number and corresponding 
percentage.15
Generalised additive model
Generalised additive model (GAM) was employed to 
model the effect of continuous variables (eg, clock hour 
for ordering the test, number of tests within 24 hours 
and pathophysiology value) on mortality outcome.16 One 
GAM was built for each variable of the interest. Since the 
mortality was a binary variable, a logistic link function was 
assigned to the GAMs. Other confounding factors such 
as the age, Sequential organ failure assessment (SOFA) 
score, gender and admission type were all entered into 
the models. Smooth terms are represented using the 
penalised regression splines (or similar smoothers) 
with smoothing parameters selected by the generalised 
cross-validation. The statistical output of GAMs was not 
directly interpretable for subject-matter audience; thus, 
the partial effect of the continuous variable of interest 
(eg, pathophysiology value, number of measurements 
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and hours of the day) was displayed by plotting the proba-
bility of mortality against each of the continuous variables.
Generalised linear model
While the GAM model helped to identify partial effects 
of the variable of interest on mortality outcome, the 
generalised linear model (GLM) was employed to report 
OR of the effects. Specifically, the continuous variables 
of interest were converted into the categorical variables, 
and then entered into the GLM for each of the variables. 
The response variable was the hospital mortality with 
logistic link function.17 18 Pathophysiology values were 
categorised according to their normal ranges, as well as 
by the cut-off points indicated by the regression splines 
used in the GAM.19 The number of measurements was 
categorised at 3, 6 and 10. Hours of the day were cate-
gorised by 6:00; 8:00, 14:00, 18:00 and 24:00 hours. For 
the investigation of the discrimination of the pathophys-
iology and healthcare process variables, the total sample 
was split into the training and testing data sets (9:1). Two 
logistic regression models were built for each laboratory 
test. Model 1 included healthcare process variables (clock 
hours, number of measurements) and pathophysiology 
value; model 2 included only the pathophysiology value. 
The two models were trained with the training data set, 
and their discriminations for predicting mortality were 
calculated using the test data set. Discriminations of the 
models were represented by the area under receiver 
operating characteristics (AUROC). AUROCs of the two 
models were compared by using the DeLong method 
for each laboratory test.20 Due to the large sample size 
and multiple comparisons in the analysis, we did not use 
p<0.05 as the cut-off for the judgement of statistical signif-
icance. Instead, we reported the point estimates along 
with CIs.21
Patient and public involvement statement
Patients and the public were not involved in the design or 
planning of the study.
resuLts
baseline characteristics of the study population
A total of 51 882 adult patients with complete ICU stay 
information were included for the analysis (excluding 
1081 patients staying in ICU for less than 24 hours). There 
were a total of 29 843 male patients (56.3%). The median 
LOS for the entire hospitalisation was 7 days (IQR: 4–13 
days). The median age of the cohort was 66 years (IQR: 
53–78 years). The admission type included emergency 
Figure 1 Distribution and impact of pathophysiology value and healthcare processes of PaO2 on mortality outcome. ICU, 
intensive care unit.
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(44 244; 83.5%), elective surgery (7391; 14.0%) and 
urgent surgery (1328; 2.5%). A total of 6531 patients 
(12.3%) died during the study period. The median LOS 
in the ICU was 2 days (IQR: 1–4 days).
GAM to investigate the relationship between the 
pathophysiology value, healthcare process and mortality
GAM for PaO2 is shown in figure 1. The distribution of 
maximum and minimum values of PaO2 is shown in the 
top two panels. While the maximum value of PaO2 showed 
two peaks at 100 and 400 mm Hg, the minimum value 
had one peak at around 80 mm Hg. Since the maximum 
value of PaO2 might reflect the corrected value such as 
the use of mechanical ventilation, it may not reflect the 
true underlying lung injury. The minimum value of PaO2 
was more likely to reflect the hypoxia status. As expected, 
the probability of the hospital death declined from 
over 25% at severe hypoxia (PaO2 <50 mm Hg) to 11% 
at PaO2 of 120 mm Hg. Thereafter, the changes in the 
morality outcome were unstable with wide CIs. The first 
panel in the third row shows the effect of hour of the day 
when PaO2 was measured on the mortality outcome. It 
appeared that PaO2 measured at 10:00 to 12:00 was asso-
ciated with the lowest risk of death. The PaO2 measured 
at 0:00 to 6:00 was associated with high risk of death. For 
the number of measurements, it reached a plateau at a 
range of 3–6 times (table 1). Patients measured for 10–15 
times for the first 24 hours showed a low mortality rate. 
However, as the PaO2 being obtained frequently, it is 
likely because another part of the blood gas was being 
followed closely. The PaO2 was a reflection of the blood 
gas measurement. Thus, we further showed the associa-
tion of healthcare processes of pH on mortality (figure 2).
Generalised linear model
The results of GLM for PaO2 are shown in table 1. Table 2 
displays a summary of the GLM results. As expected, 
pathophysiology values within the normal range were 
consistently associated with the lowest mortality for all 
laboratory tests. The number of tests associated with lowest 
mortality varied among these laboratory tests. Lower 
number of tests such as 1–3 times were associated with 
the lowest mortality for most laboratory tests. However, 
the hematocrit, glucose and potassium required 6–10 
measurements for the first 24 hours to reach the lowest 
mortality rate. The derangements in these blood parame-
ters are associated with acute pathophysiological deterio-
ration or even sudden death. Therefore, close monitoring 
of these blood parameters is required to improve survival 
outcome. For example, hyperkalaemia can cause sudden 
cardiac arrest, acute drop in hematocrit is an indication 
of massive bleeding and hypoglycaemia can cause irre-
versible brain injury. Other tests such as albumin, WBC 
and bicarbonate were not a reflection of sudden dete-
rioration, but were associated with survival outcome. 
However, if some urgent tests such as hematocrit, glucose 
and potassium were not ordered within 24 hours after 
ICU admission, the mortality rate could get escalated. For 
most of the tests, the measurement at 00:00–6:00 hours 
was associated with the lowest mortality rate.
Comparison of models with and without healthcare process 
variables
Comparison of models with and without healthcare 
process variables is shown in table 3. For albumin, hema-
tocrit and potassium, the addition of healthcare process 
variables was not associated with improved prediction 
accuracy, as compared with the model with pathophysi-
ology value alone. For other laboratory tests, the addition 
of healthcare process variables was associated with signifi-
cantly increased AUROC.
Table 1 OR for the association of healthcare process 
variables and hospital mortality by adjusting for 
pathophysiological value of PaO2
Variables OR (95% CI) P value
Age (with every 1 year 
increase)
1.03 (1.02 to 1.03) <0.001
Gender (female as 
reference)
0.93 (0.88 to 0.99) 0.026
Admission type (elective as reference)
  Emergency 3.61 (3.14 to 4.16) <0.001
  Urgent 3.25 (2.59 to 4.08) <0.001
  SOFA (with every 1  point 
increase)
1.32 (1.31 to 1.33) <0.001
Number of measurement (none as reference)*
  1–3 2.11 (1.76 to 2.53) <0.001
  3–6 2.02 (1.59 to 2.56) <0.001
  6–10 1.08 (0.83 to 1.41) 0.558
  >10 0.59 (0.44 to 0.80) 0.001
Minimum PaCO2 (<50 mm Hg as reference)
  >150 mm Hg 1.06 (0.92 to 1.23) 0.425
  50–70 mm Hg 0.82 (0.72 to 0.94) 0.004
  70–80 mm Hg 0.63 (0.54 to 0.73) <0.001
  80–150 mm Hg 0.64 (0.56 to 0.72) <0.001
Clock time
  0:00–6:00 1.10 (1.00 to 1.22) 0.112
  6:00–8:00 0.93 (0.85 to 1.02) 0.015
  8:00–14:00 0.89 (0.80 to 0.98) 0.054
  14:00–18:00 0.91 (0.84 to 1.00) 0.417
  18:00–24:00 0.96 (0.88 to 1.06) 0.009
Measurement time from ICU admission (none as reference)
  Within 6 hours 1.19 (1.04 to 1.35) 0.163
  From 6 to 12 hours 1.07 (0.97 to 1.19) <0.001
  Above 12 hours 1.32 (1.19 to 1.47) <0.001
*The number of measurements was calculated as the number 
of measurements ordered within the first 24 hours after ICU 
admission. The generalised linear model was employed for binary 
outcome mortality.
ICU, intensive care unit; PaO2, arterial PaO2 of oxygen.
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DIsCussIOn
Our study found that healthcare processes (eg, clock time 
of laboratory tests, number of measurements and the time 
from ICU admission to tests) of the laboratory tests were 
independently associated with the hospital mortality; and 
the addition of the healthcare processes to the patho-
physiology value could increase the discrimination for 
mortality outcome. The healthcare process patterns of 
the laboratory tests were different according to the type 
of tests. For example, 6–10 measurements of hematocrit, 
glucose and potassium for the first 24 hours after the ICU 
admission were associated with the lowest mortality rate. 
For other less urgent tests such as BUN, WBC and creat-
inine, one to three measurements in the first 24 hours is 
associated with the lowest mortality.
The healthcare process of laboratory tests has been 
investigated in hospitalised patients. Agniel and coworkers 
enrolled 669 452 hospitalised patients and investigated 
the association of healthcare process of laboratory tests 
and 3 year survival.5 They found that the WBC measured 
in the early morning was associated with the highest risk of 
death (eg, the lowest mortality was likely achieved among 
the people with no tests at all), which is in contrast to 
the findings in our study that WBC measured in the early 
morning was associated with the lowest hospital mortality. 
This could be explained by the different settings of the two 
studies. There was a substantial difference in the health-
care process in ICU and general hospital wards and/
or outpatient. It can be proposed that close monitoring 
for ICU patients is required to circumvent catastrophic 
deterioration, and measurements outside daytime hours 
might help to identify potential lethal conditions and 
thus to improve outcome. Another explanation is that 
the physician will typically stop treatment if the chance of 
survival is very low. Perhaps this is why high ICU mortality 
was seen when tests were not ordered.22 However, the 
condition can be different for general ward or outpatient, 
if a measurement outside of daytime hour is ordered, it 
is suggestive of poor conditions irrespective of the patho-
physiology value of the test. Agniel’s study showed that 
the predictive models combined with the pathophysi-
ology values and healthcare process were better than the 
models with either dimension alone in 168 out of the 272 
(68%) investigated laboratory tests. The result was consis-
tent with our study that nine out of 12 (75%) of the tests 
had the better predictive model with both dimensions 
included.
Figure 2 Distribution and impact of pathophysiology value and healthcare processes of pH on mortality outcome. ICU, 
intensive care unit.
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There are several clinical implications brought by the 
present study. First, although a causal statement cannot 
be made, this study indicates that physicians should 
not delay or omit ordering some critical tests such as 
glucose, hematocrit and potassium for ICU patients. 
Second, different patterns of healthcare process could be 
identified for different tests, and such information can 
be employed to identify outlier clinicians or practices. 
Third, healthcare process modelling can be incorporated 
into the assessment of the severity of illness within the 
first 24 hours after ICU admission. Some laboratory tests 
required in severity scores might be missing, and current 
modelling practice is to impute missing values or simply 
exclude patients with missing values.23 However, our study 
found that the missing value per se carried important 
prognostic information and should be added to the assess-
ment of the severity of illness. Similarly, a test ordered in 
the early morning can be different from that ordered at 
night. These healthcare process variables can be added 
to modelling predictive models. Fourth, healthcare 
process dimension can be incorporated into designing 
clinical studies. Randomised controlled trials (RCT) are 
often designed to minimise variations in clinical practice, 
which is a reason for the difference in effect sizes between 
the RCT and real-world setting.24 25 Since the healthcare 
process carries important prognostic information, trials 
can be designed by a pragmatic stratification of patients 
according to likely disease severity according to health-
care process variables.
There are several limitations in the current study. First, 
the study investigated only 12 tests and it is unknown 
whether the results could be generalised to other tests. 
These 12 tests were specifically chosen because they were 
important prognostic tests in the first 24 hours after ICU 
admission (eg, the tests included in the acute physiology 
score for APACHE III). Other less commonly ordered 
tests were not included because they would produce spar-
sity in the data frame. Second, the study was based on a 
single centre and the healthcare process pattern may not 
be generalisable to other institutions, because the timing 
and frequency of tests can depend on local hospital prac-
tice patterns. However, we believe that the healthcare 
process variables can add more prognostic information 
to the pathophysiology values, irrespective of what health-
care process pattern it is. Furthermore, the healthcare 
processes can be influenced by the control of the practi-
tioner, and it would be better to included variables unlikely 
being changed by preferences for predictive purpose. 
Third, underlying reasons for repeated measurements 
within 24 hours could not be investigated in the study, 
which was a source of bias known as the confounding 
by indication. For example, repeated measurements of 
PaO2 can be indicative of deteriorating respiratory func-
tion, or simply due to routines for patients on mechanical 
ventilation. These issues can be addressed specifically for 
each test in future studies.T
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COnCLusIOn
In conclusion, this study shows that the healthcare 
processes of laboratory tests were independently asso-
ciated with the hospital mortality; and the addition of 
these healthcare process variables to the pathophysiology 
value could increase the discrimination of the model for 
predicting the mortality outcome. However, variations of 
the impacts of healthcare process on mortality exist for 
different tests, which requires further investigations.
Contributors ZZ conceived of the study; YH carried out data entry. YH participated 
in the data check and interpretation. ZZ performed statistical analysis and drafted 
the manuscript. TL and HG helped to review and interpret the results. All authors 
read and approved the final manuscript. ZZ is the guarantor of the paper.
Funding ZZ received funding from the public welfare research project of Zhejiang 
province (LGF18H150005) and scientific research project of Zhejiang Education 
Commission (Y201737841).
Competing interests None declared.
Patient consent for publication Not required.
ethics approval The study was an analysis of the third party anonymised publicly 
available database with pre-existing institutional review board approval. ZZ had 
obtained permission to access the database after completion of the course Data or 
Specimens Only Research (approval no: 28776374). 
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The data were available by contacting the authors.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Jones PM, Cherry RA, Allen BN, et al. Association Between handover 
of anesthesia care and adverse postoperative outcomes among 
patients undergoing major surgery. JAMA 2018;319:143–53.
 2. Schütte-Nütgen K, Thölking G, Dahmen M, et al. Is there 
a "weekend effect" in kidney transplantation? PLoS One 
2017;12:e0190227.
 3. Hirschy R, Sterk E, Dobersztyn R, et al. Time Spent in the Emergency 
Department and Outcomes in Patients With Severe Sepsis and 
Septic Shock. Adv Emerg Nurs J 2018;40:94–103.
 4. Ramsden L, McColgan MP, Rossor T, et al. Paediatric outcomes and 
timing of admission. Arch Dis Child 2018;103:611–7.
 5. Agniel D, Kohane IS, Weber GM. Biases in electronic health record 
data due to processes within the healthcare system: retrospective 
observational study. BMJ 2018;361:k1479.
 6. Weber GM, Kohane IS. Extracting physician group intelligence from 
electronic health records to support evidence based medicine. PLoS 
One 2013;8:e64933.
 7. Buck DL, Christiansen CF, Christensen S, et al. Out-of-hours 
intensive care unit admission and 90-day mortality: a Danish 
nationwide cohort study. Acta Anaesthesiol Scand 2018;62:77.
 8. Brunot V, Landreau L, Corne P, et al. Mortality Associated with Night 
and Weekend Admissions to ICU with On-Site Intensivist Coverage: 
Results of a Nine-Year Cohort Study (2006-2014). PLoS One 
2016;11:e0168548.
 9. Zampieri FG, Lisboa TC, Correa TD, et al. Role of organisational 
factors on the 'weekend effect' in critically ill patients in Brazil: a 
retrospective cohort analysis. BMJ Open 2018;8:e018541.
 10. Yang S, Wang Z, Liu Z, et al. Association between time of discharge 
from ICU and hospital mortality: a systematic review and meta-
analysis. Crit Care 2016;20:390.
 11. Johnson AE, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible 
critical care database. Sci Data 2016;3:160035.
 12. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic 
system. Risk prediction of hospital mortality for critically ill 
hospitalized adults. Chest 1991;100:1619–36.
 13. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of 
disease classification system. Crit Care Med 1985;13:818–29.
 14. Chan T, Bleszynski MS, Buczkowski AK. Evaluation of APACHE-
IV predictive scoring in surgical abdominal sepsis: a retrospective 
cohort study. J Clin Diagn Res 2016;10:PC16–18.
 15. Zhang Z. Univariate description and bivariate statistical inference: the 
first step delving into data. Ann Transl Med 2016;4:91.
 16. Wood SN. Generalized additive models: an introduction with R. 2nd 
ed: Chapman and Hall/CRC, 2017.
 17. Zhang Z. Model building strategy for logistic regression: purposeful 
selection. Ann Transl Med 2016;4:111.
 18. Tolles J, Meurer WJ. Logistic regression: relating patient 
characteristics to outcomes. JAMA 2016;316:533–4.
 19. Zhang Z, Zhang H, Khanal MK. Development of scoring system for 
risk stratification in clinical medicine: a step-by-step tutorial. Ann 
Transl Med 2017;5:436.
Table 3 Discrimination performance of laboratory test for the prediction of hospital mortality in logistic regression models with 
and without healthcare process variables
Variables AUC for model 1 (95% CI) AUC for model 2 (95% CI) P value*
PaO2 0.664 (0.634 to 0.694) 0.639 (0.609 to 0.670) 0.001
Hematocrit 0.605 (0.573 to 0.636) 0.583 (0.554 to 0.613) 0.147
Potassium 0.612 (0.580 to 0.644) 0.600 (0.570 to 0.631) 0.356
Albumin 0.594 (0.567 to 0.622) 0.590 (0.563 to 0.618) 0.333
Glucose 0.630 (0.601 to 0.660) 0.555 (0.534 to 0.575) <0.001
Bilirubin 0.611 (0.581 to 0.640) 0.603 (0.574 to 0.632) 0.022
Bicarbonate 0.692 (0.661 to 0.723) 0.664 (0.635 to 0.694) 0.001
WBC 0.634 (0.603 to 0.666) 0.610 (0.580 to 0.641) 0.015
BUN 0.681 (0.650 to 0.712) 0.665 (0.635 to 0.695) 0.025
pH 0.665 (0.635 to 0.695) 0.636 (0.605 to 0.666) 0.001
Sodium 0.615 (0.583 to 0.647) 0.587 (0.558 to 0.616) 0.043
Creatinine 0.671 (0.640 to 0.701) 0.620 (0.590 to 0.650) <0.001
*The AUCs of two ROC curves were compared using DeLong method, and p values for the comparisons were reported.
Model 2 included only the pathophysiology value; model 1 included healthcare process variables (number of test for the first 24 hours, clock 
time of the test and the measurement time relative to ICU admission) and the pathophysiology value of corresponding test.
AUC, area under curve; BUN, blood urea nitrogen; ROC, receiver operating characteristic; WBC, white cell count.
Protected by copyright.
 o
n
 January 19, 2020 at Kobenhavns Universitets Bibliotek.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-028101 on 24 June 2019. Downloaded from 
8 Zhang Z, et al. BMJ Open 2019;9:e028101. doi:10.1136/bmjopen-2018-028101
Open access 
 20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the Areas 
under Two or More Correlated Receiver Operating Characteristic 
Curves: A Nonparametric Approach. Biometrics 1988;44:837.
 21. Lederer DJ, Bell SC, Branson RD, et al. Control of confounding and 
reporting of results in causal inference studies. guidance for authors 
from editors of respiratory, sleep, and critical care journals. Ann Am 
Thorac Soc 2019;16:22–8.
 22. Wilkinson DJC, Savulescu J. Knowing when to stop: futility in the 
ICU. Curr Opin Anaesthesiol 2011;24:160–5.
 23. Zhang Z. Missing data imputation: focusing on single imputation. 
Ann Transl Med 2016;4:9.
 24. Oude Rengerink K, Kalkman S, Collier S, et al. Series: Pragmatic 
trials and real world evidence: Paper 3. Patient selection challenges 
and consequences. J Clin Epidemiol 2017;89:173–80.
 25. Zhang Z. Big data and clinical research: focusing on the area of 
critical care medicine in mainland China. Quant Imaging Med Surg 
2014;4:426–9.
Protected by copyright.
 o
n
 January 19, 2020 at Kobenhavns Universitets Bibliotek.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-028101 on 24 June 2019. Downloaded from 
